83 percent of respondents will be decreasing R&D spending if the medical device tax is reinstated, which ultimately harms patients as they are forced to wait longer for new innovations to reach their bedside, and 67 percent of respondents indicated they will be delaying or forgoing planned hiring. An additional 47 percent said they would suspend plans to physically expand their business.
Briefed on the results of the survey, the Medical Alley Association president and CEO, Shaye Mandle, said: “These results confirm what we’ve heard in private meetings: the medical device tax actively chills innovation and disproportionately hurts small businesses. There is bipartisan support for repealing the tax and we urge Congress to act before the end of the year.”
The Medical Alley Association is grateful for the leadership Minnesota politicians have shown on this issue, particularly Gov. Tim Walz, Rep. Dean Phillips, Rep. Tom Emmer, Rep. Angie Craig, Rep. Pete Stauber, Rep. Collin Peterson, Rep. Jim Hagedorn, Sen. Amy Klobuchar, and Sen. Tina Smith. Minnesota would be disproportionately affected by the return of the tax given the number of small- and medium-sized manufacturers that have chosen the state as their home because of the Medical Alley community. Since the tax is levied on revenues rather than profits, these businesses would bear the brunt of its impact, as many of them are still working on getting their flagship device to market.
There is broad, bipartisan support for removing the tax and strong reasons for congress to do so. Congress must act decisively to support innovation in healthcare and remove the medical device excise tax before it further drives up the cost of healthcare.